Ambee Pharmaceuticals Limited reported earnings results for the full year ended June 30, 2021. For the full year, the company reported sales was BDT 98.98 million compared to BDT 285.3 million a year ago. Net loss was BDT 13.01 million compared to net income of BDT 3.64 million a year ago.

Basic loss per share from continuing operations was BDT 4.5167 compared to basic earnings per share from continuing operations of BDT 1.2667 a year ago.